Smith Devin Whittemore
- SEC CIK
- 0001747818
No open-market purchases or sales filed in the past year.
Current role at each company
- IOBT IO Biotech, Inc.General Counselas of Apr 4, 2025
- KA Kineta, Inc.SVP and General Counselas of Dec 6, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Smith Devin Whittemore as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
IOBT IO Biotech, Inc.
General Counsel1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 23, 2024 (view filing) | Dec 23 | Same day | Smith Devin WhittemoreGeneral Counsel | PPurchase | +12.0K | $0.81 | +$9.72K | +243.0%16.9K after |
KA Kineta, Inc.
SVP and General Counsel2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 6, 2022 (view filing) | Dec 2 | 4 days | Smith Devin WhittemoreSVP and General Counsel | SSale | −3.12K | $1.69 | −$5.27K | −18.2%14.0K after | |
| Jun 6, 2022 (view filing) | Jun 3 | 3 days | Smith Devin WhittemoreSVP and General Counsel | SSale | −2.92K | $1.19 | −$3.48K | −14.6%17.1K after |